Themis Medicare Limited

NSE THEMISMED.NS

Themis Medicare Limited Free Cash Flow for the year ending March 31, 2024: USD 440.68 K

Themis Medicare Limited Free Cash Flow is USD 440.68 K for the year ending March 31, 2024, a 128.62% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Themis Medicare Limited Free Cash Flow for the year ending March 31, 2023 was USD -1.54 M, a -184.93% change year over year.
  • Themis Medicare Limited Free Cash Flow for the year ending March 31, 2022 was USD 1.81 M, a -65.90% change year over year.
  • Themis Medicare Limited Free Cash Flow for the year ending March 31, 2021 was USD 5.32 M, a 831.46% change year over year.
  • Themis Medicare Limited Free Cash Flow for the year ending March 31, 2020 was USD -726.97 K, a -195.52% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
NSE: THEMISMED.NS

Themis Medicare Limited

CEO Dr. Sachin Dinesh Patel CChem., Ph.D.
IPO Date April 2, 2007
Location India
Headquarters 11/12 Udyog Nagar Industrial Estate
Employees 1,509
Sector Health Care
Industries
Description

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.

Similar companies

SMSPHARMA.NS

SMS Pharmaceuticals Limited

USD 2.55

2.90%

RPGLIFE.NS

RPG Life Sciences Limited

USD 23.77

2.82%

TIIL.NS

Technocraft Industries (India) Limited

USD 31.41

-0.43%

GUFICBIO.NS

Gufic Biosciences Limited

USD 5.42

-1.33%

VENUSREM.NS

Venus Remedies Limited

USD 3.40

2.16%

StockViz Staff

January 16, 2025

Any question? Send us an email